Clinical Trial Update: Study Comparing Daclatasvir (BMS-790052) With Telaprevir Combined With Peginterferon Alfa-2a and Ribavirin in Patients With Chronic Hepatitis C Virus Infection [Phase 3]

View source ↗

Summary

A Phase 3 trial comparing daclatasvir to telaprevir combined with peginterferon alfa-2a and ribavirin in adults with chronic hepatitis C virus infection; result…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis C

Drugs mentioned

• Daclatasvir (daclatasvir)
• Peginterferon alfa-2a (peginterferon alfa-2a)
• Ribavirin (ribavirin)
• Telaprevir (telaprevir)

Snippet

Sponsor: Bristol-Myers Squibb | Conditions: Hepatitis C | Phase 3 | Status: COMPLETED | Results posted: 2016-06-03